文献リスト

1) Kay AB. “Helper"(CD4＋) T cells and eosinophils in allergy and asthma. Am Rev Respir Dis. 1992; 145: S22-6

2) Hamid Q, Azzawi M, Ying S, et al. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest. 1991; 87: 1541-6

3) Humbert M, Corrigan CJ, Kimmitt P, et al. Relationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthma. Am J Respir Crit Care Med. 1997; 156: 704-8

4) Robinson D, Hamid Q, Ying S, et al. Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-γ cytokine gene expression. Am Rev Respir Dis. 1993; 148: 401-6

5) Ying S, Humbert M, Barkans J, et al. Expression of IL-4 and IL-5 mRNA and protein product by CD4＋ and CD8＋ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J Immunol. 1997; 158: 3539-44

6) Humbert M, Durham SR, Ying S, et al. IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and non-atopic asthmatics: evidence against“intrinsic"asthma being a distinct immunopathological entity. Am J Respir Crit Care Med. 1996; 154: 1497-504

7) Ohnishi T, Kita H, Weiler D, et al. IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction. Am Rev Respir Dis. 1993; 147: 901-7

8) Virchow JCJ, Walker C, Hafner D. T cells and cytokines in bronchoalveolar lavage fluid after segmental allergen provocation in atopic asthma. Am J Respir Crit Care Med. 1995; 151: 960-8

9) Bentley AM, Hamid Q, Robinson DS. Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa. Am J Respir Crit Care Med. 1996; 153: 551-6

10) Robinson DS, Ying S, Bentley AM, et al. Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma. J Allergy Clin Immunol. 1993; 92: 397-403

11) Marsland BJ, Gros GL. CD8＋ T cells and immunoregulatory networks in asthma. Springer Semin Immunol. 2004; 25: 311-23

12) McMenamin C, Holt PG. The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8＋ T cell-mediated but MHC class II-restricted CD4＋ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production. J Exp Med. 1993; 178: 889-99

13) Komai M, Tanaka H, Masuda T, et al. Role of Th2 responses in the development of allergen-induced airway remodelling in a murine model of allergic asthma. Br J Pharmacol. 2003; 138: 912-20

14) Olivenstein R, Renzi PM, Yang JP, et al. Depletion of OX-8 lymphocytes from the blood and airways using monoclonal antibodies enhances the late airway response in rats. J Clin Invest. 1993; 92: 1477-82

15) Huang TJ, MacAry PA, Kemeny DM, et al. Effect of CD8＋ T-cell depletion on bronchial hyper-responsiveness and inflammation in sensitized and allergen-exposed Brown-Norway rats. Immunology. 1999; 96: 416-23

16) Suzuki M, Taha R, Ihaku D, et al. CD8＋ T cells modulate late allergic airway responses in Brown Norway rats. J Immunol. 1999; 163: 5574-81

17) Renz H, Lack G, Saloga J, et al. Inhibition of IgE production and normalization of airways responsiveness by sensitized CD8 T cells in a mouse model of allergen-induced sensitization. J Immunol. 1994; 152: 351-60

18) Wells JW, Cowled CJ, Giorgini A, et al. Regulation of allergic airway inflammation by class I-restricted allergen presentation and CD8 T-cell infiltration. J Allergy Clin Immunol. 2007; 119: 226-34

19) O'Sullivan S, Cormican L, Faul JL, et al. Activated, cytotoxic CD8(＋) T lymphocytes contribute to the pathology of asthma death. Am J Respir Crit Care Med. 2001; 164: 560-4

20) Lee SY, Kim SJ, Kwon SS, et al. Distribution and cytokine production of CD4 and CD8 T-lymphocyte subsets in patients with acute asthma attacks. Ann Allergy Asthma Immunol. 2001; 86: 659-64

21) Cho SH, Stanciu LA, Holgate ST, et al. Increased interleukin-4, interleukin-5, and interferon-gamma in airway CD4＋ and CD8＋ T cells in atopic asthma. Am J Respir Crit Care Med. 2005; 171: 224-30

22) van Rensen EL, Sont JK, Evertse CE, et al. Bronchial CD8 cell infiltrate and lung function decline in asthma. Am J Respir Crit Care Med. 2005; 172: 837-41

23) Coyle AJ, Erard F, Bertrand C, et al. Virus-specific CD8＋ cells can switch to interleukin 5 production and induce airway eosinophilia. J Exp Med. 1995; 181: 1229-33

24) Seder RA, Le Gros GG. The functional role of CD8＋ T helper type 2 cells. J Exp Med. 1995; 181: 5-7

25) Koya T, Miyahara N, Takeda K, et al. CD8＋ T cell-mediated airway hyperresponsiveness and inflammation is dependent on CD4＋IL-4＋ T cells. J Immunol. 2007; 179: 2787-96

26) Stock P, Kallinich T, Akbari O, et al. CD8(＋) T cells regulate immune responses in a murine model of allergen-induced sensitization and airway inflammation. Eur J Immunol. 2004; 34: 1817-27

27) Humbert M. Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma. J Allergy Clin Immunol. 1997; 99: 657-65

28) Huang S-K, Xiao H-Q, Kleine-Tebbe J, et al. IL-13 expression at the sites of allergen challenge in patients wish asthma. J Immunol. 1995; 155: 2688-94

29) Katagiri K, Itami S, Hatano Y, et al. Incresed levels of IL-13 mRNA, but not IL-4 mRNA, are found in vivo in peripheral blood mononuclear cells (PBMC) of patients with atopic dermatitis (AD). Clin Exp Immunol. 1997; 108: 289-94

30) Pawankar RU. Interleukin-13 expression in the nasal mucosa of perennial allergic rhinitis. Am J Respir Crit Care Med. 1995; 152: 2059-67

31) Akdis M, Akdis CA, Weigl L, et al. Skinhoming, CLA＋ memory T cells are activated in atopic dermatitis and regulate IgE by an IL-13-dominated cytokine pattern: IgG4 counter-regulation by CLA-memory T cells. J Immunol. 1997; 159: 4611-9

32) Heinzmann A, Mao XQ, Akaiwa M, et al. Genetic variants of IL-13 signalling and human asthma and atopy. Hum Mol Genetics. 2000; 9: 549-59

33) Graves PE, Kabesch M, Halonen M, et al. A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children. J Allergy Clin Immunol. 2000; 105: 506-13

34) Zhu Z, Homer RJ, Wang Z, et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest. 1999; 103: 779-88

35) Zuhdi Alimam M, Piazza FM, Selby DM, et al. Muc-5/5ac mucin messenger RNA and protein expression is a marker of goblet cell metaplasia in murine airways. Am J Respir Cell Mol Biol. 2000; 22: 253-60

36) Wills-Karp M, Luyimbazi J, Xu X, et al. Interleukin-13: central mediator of allergic asthma. Science. 1998; 282: 2258-61

37) Grunig G, Warnock M, Wakil AE, et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science. 1998; 282: 2261-3

38) Tager AM, Bromley SK, Medoff BD, et al. Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment. Nat Immunol. 2003; 4: 982-90

39) Miyahara N, Takeda K, Miyahara S, et al. Leukotriene B4 receptor-1 is essential for allergen-mediated recruitment of CD8＋ T cells and airway hyperresponsiveness. J Immunol. 2005; 174: 4979-84

40) Miyahara N, Swanson BJ, Takeda K, et al. Effector CD8＋ T cells mediate inflammation and airway hyper-responsiveness. Nat Med. 2004; 10: 865-9

41) Miyahara N, Takeda K, Miyahara S, et al. Requirement for leukotriene B4 receptor 1 in allergen-induced airway hyperresponsiveness. Am J Respir Crit Care Med. 2005; 172: 161-7

42) Gelfand EW, Dakhama A. CD8＋ T lymphocytes and leukotriene B4: novel interactions in the persistence and progression of asthma. J Allergy Clin Immunol. 2006; 117: 577-82

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp